Week ending Friday, October 24, 2026 · Published by QuantLogix Research
A second consecutive volatile tape closed with the Dow sinking 600 points Friday and the Nasdaq extending its AI-led unwind as investors challenged hyperscaler cap-ex math. Defense primes vaulted on blockbuster Q3 beats, Tesla and Netflix delivered mixed prints, and the market now looks to a pivotal FOMC decision on October 28–29.
Levels are approximate end-of-week prints; weekly % tracks Friday-to-Friday close. Friday's Dow drop of ~600 points was the week's defining tape. Breadth deteriorated further: NYSE advance-decline closed negative in four of five sessions.
Industrials led on defense-prime earnings; Health Care continued its grind to records. Tech and Comm Services absorbed the second leg of the AI unwind, with SpaceX funding worries dragging telecom-adjacent names and dampening satellite-infrastructure exposure.
Thursday's S&P Global flash PMIs printed softer across the board: Manufacturing 49.3 (prior 50.4), Services 51.9 (prior 53.2), and the composite easing to 51.0. New orders decelerated; employment sub-indices suggested cooling labor demand. Combined with last week's hot CPI, the data pattern is textbook late-cycle: sticky inflation, softening activity — the stagflation-lite setup markets have been dreading.
Rates reacted. The 10-year yield slipped to 5.03% (from 5.10% last Friday) as growth-sensitive repricing dominated the inflation signal; the 2-year fell to 4.31%. Fed-funds futures now embed a ~70% probability of a 25bps cut at next week's FOMC — a sharp swing from mid-week pricing of a hold, and a near-complete reversal from the hike risk flagged after last week's CPI.
The Fed's path has become asymmetric: a cut validates the growth-slowdown signal and lifts duration; a hold leans into the inflation data and risks a 10-year retest of 5.20%. Our dot-plot nowcaster puts the probability of at least one cut by year-end at 82%, up from 58% a week ago. Chair Powell's press-conference language around “data-dependent flexibility” is the single most important deliverable.
If last week was about financing stress at AI-infrastructure capital stacks, this week forced the question of earnings. Tesla delivered Q3 revenue in line but EPS missed on an R&D step-up tied to robotaxi and Optimus platforms; shares slid ~5% post-print. Netflix topped revenue at $12.87B with subscriber adds beating but forward margin guidance disappointed; shares fell ~4%. IBM beat on consulting-software mix but tempered expectations on 2027 cap-ex, closing roughly flat on the week.
The deeper problem: retail positioning. Flow data showed retail traders aggressively bought the AI-spending winners into early October — CoreWeave, Palantir, Oracle, Vertiv, Micron — and are now unwinding. That dynamic is extending the pain. The SOXX ETF logged another −3.8% on the week; CoreWeave fell a further ~8% as credit spreads widened; Palantir dropped another ~6%.
Yet the underlying demand picture remains asymmetric to the downside only if cap-ex paybacks don't materialize. Nvidia's November print is now the most important single data event of Q4 — a decisive Blackwell/Rubin visibility beat would snap the narrative; a soft tone would confirm the funding-math anxiety. Supplier color from Lam Research and KLA next week will set the stage.
| Name | WoW |
|---|---|
| CRWV CoreWeave | −8.1% |
| PLTR Palantir | −6.2% |
| TSLA Tesla | −5.0% |
| NFLX Netflix | −4.1% |
| NVDA Nvidia | −3.3% |
| META Meta Platforms | −2.8% |
| MSFT Microsoft | −1.4% |
| IBM IBM | +0.2% |
The Q3 reports from the top defense primes delivered the strongest cohort beat of the earnings season. Lockheed Martin (LMT) headlined: Wednesday's print showed record backlog, raised full-year EPS guidance, and a top-line beat driven by F-35 sustainment, PAC-3 missile throughput, and classified Space work. Shares jumped ~9% intraday — the largest single-day move for LMT since 2022 — before closing +6.4% on the week.
RTX Corporation added ~2% on strong Collins Aerospace and Pratt & Whitney order books; Northrop Grumman gained ~3% on classified B-21 program milestones; General Dynamics and L3Harris both finished green on steady order flows. Three of the top five primes raised full-year guidance; two posted record backlogs. The subsector — already outperforming on geopolitical rotation — now has fundamental air cover.
Defense factor remains at Overweight; our geopolitical-stress composite stayed above the 70th percentile all week, and the Pentagon-contract-flow nowcaster accelerated. Book-to-bill is now 1.22 across the top four primes (vs. 1.1 last week). Relative strength vs. S&P 500 widened to +9.3% over 90 days. Risk: an abrupt de-escalation thesis or a continuing-resolution hiccup in appropriations.
| Name | WoW |
|---|---|
| LMT Lockheed Martin | +6.4% |
| NOC Northrop Grumman | +3.1% |
| RTX RTX Corp. | +2.3% |
| GD General Dynamics | +2.0% |
| LHX L3Harris | +1.5% |
| HII Huntington Ingalls | +1.3% |
| LDOS Leidos | +1.0% |
The S&P 500 Health Care sector (XLV) printed a fresh all-time high Tuesday as large-cap pharma, device makers and managed care continued to absorb defensive-rotation flows. Eli Lilly (LLY) gained another ~3% as physician-prescribed obesity data and GLP-1 franchise momentum carried into Q4 commentary; UnitedHealth added ~2% on calmer MLR commentary from peers.
Beneath the index, biotech dispersion remained extreme. Moderna (MRNA) rebounded ~4% after last week's profit-taking, buoyed by melanoma-vaccine Phase 3 readout anticipation at the medical meeting later this month. Regeneron (REGN) firmed ahead of its Q3 print; Vertex Pharma (VRTX) edged up on CF franchise visibility; BioNTech (BNTX) and Amgen (AMGN) both report into the next earnings window.
The XBI biotech ETF held flat on the week, with upside concentrated in oncology and obesity thematic baskets; molecular-glue and ADC franchises continued to attract M&A chatter. Credit spreads widening is the primary risk for mid-cap biotech — a cohort that trades like a short-duration credit proxy — and remains the signal to watch into November.
| Name | WoW |
|---|---|
| LLY Eli Lilly | +3.0% |
| MRNA Moderna | +4.1% |
| UNH UnitedHealth | +2.0% |
| VRTX Vertex Pharma | +1.4% |
| REGN Regeneron | +1.1% |
| JNJ Johnson & Johnson | +0.9% |
| XBI SPDR Biotech ETF | +0.1% |
| Company | Revenue | EPS | WoW | Notable |
|---|---|---|---|---|
| TSLA Tesla |
$26.4B | $0.69 | −5.0% | Margin rebound; R&D step-up on Optimus/robotaxi |
| NFLX Netflix |
$12.87B | $6.42 | −4.1% | Subs beat; forward margin guide trimmed |
| IBM IBM |
$16.1B | $2.44 | +0.2% | Consulting/software mix; 2027 cap-ex caution |
| LMT Lockheed Martin |
$18.6B | $7.65 | +6.4% | Record backlog; raised FY guidance; jet & missile ramp |
| BA Boeing |
$18.9B | $(0.84) | −2.6% | 737 cash-burn improving; defense drag |
| GM General Motors |
$46.2B | $2.17 | +1.8% | Trucks/SUVs resilient; EV losses contained |
| KO Coca-Cola |
$12.1B | $0.80 | +1.4% | Price/mix 7%; organic growth 6%; FX headwind |
The dispersion story: defense primes and consumer-staples defensives beat clean; mega-cap tech beat on top line but missed on guidance quality or expense trajectory. The forward P/E compression in the Mag-7 cohort is the market's single most important chart heading into November's hyperscaler prints.
Gold spot held near $4,105/oz (+0.7% on the week), consolidating last week's record while central-bank buying and ETF inflows continued at pace. YTD gold is +54%. Silver eased modestly to $50.20/oz as momentum oscillators worked off overbought signals; platinum and palladium were little changed.
In energy, Brent slipped back to $107.20 as reports of partial Hormuz de-escalation and SPR-release optionality capped the geopolitical premium. WTI settled near $96. Natural gas firmed on an early-season cold front; copper gave back some of last week's gains on China PMI commentary.
The dollar held firm into FOMC week as safe-haven demand offset the softer-rate repricing; the DXY sat at 104.4. Yen briefly tested 156/USD before easing on BoJ chatter; the euro drifted lower on softer eurozone PMIs. The Swiss franc and gold both reclaimed safe-haven leadership.
Crypto was mixed. Bitcoin consolidated in a tight range around $82,000, holding the 200-day as spot ETF flows ticked back positive late in the week. Ethereum was flattish; the ETH/BTC ratio sat near multi-year lows. Solana outperformed on L1 TVL headlines; stablecoin supply hit a fresh high. Credit spreads widening remains the key cross-asset tell for the crypto-risk corridor.
The quarter's heaviest earnings week lands: Microsoft, Alphabet, Meta, Amazon, Apple all report between Tuesday and Thursday, with AMD, Qualcomm, Visa, ExxonMobil, Chevron, Mastercard, Pfizer, Merck, Caterpillar rounding out the slate. Capital-expenditure guidance from the four cloud hyperscalers is the single most important data stream for the AI-infrastructure debate — both scale and payback cadence.
Semiconductor supplier color from Lam Research and KLA precedes the Mag-7 week. Nvidia's own print follows in mid-November, but any order-book guidance from the suppliers will precondition positioning materially.
Tuesday: Case-Shiller home prices, Conference Board consumer confidence, JOLTS job openings · Wednesday: FOMC statement & press conference (2:00pm / 2:30pm ET) · Thursday: Advance Q3 GDP (first print), weekly jobless claims · Friday: September Core PCE — the Fed's preferred inflation gauge — plus personal income & spending.
Markets are pricing a ~70% cut probability for Wednesday. The press conference is the whole game: a hawkish cut tightens financial conditions despite the move; a dovish hold eases them. Core PCE Friday is the inflation hinge for December pricing.
Our signal governor flipped to Defensive Tilt (85/100) on Thursday; the Mag-7 earnings super-week and the FOMC decision will determine whether this is a corrective pause or the start of a durable regime shift. Breadth thrust triggers (McClellan oscillator, % of 500 above 50-day) remain our primary unlock conditions.